2.29
-4.98%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Check Cap
Its shares trade under the ticker MBAI. It has been listed since 19 February 2015.
Check-Cap Ltd. is a clinical stage medical diagnostics company engaging in the development of ingestible imaging capsule system for colorectal cancer screening. The company employs 65 full-time employees The company went IPO on 2015-02-19. The firm develops C-Scan, capsule-based, system ingestible imaging for colorectal cancer screening.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Listed since
- 19 Feb 2015
- Employees
- 65
- Website
- check-cap.com ↗
- Head office
- ABBA HUSHI AVENUE, ISFIYA, 000000
- Incorporated in
- L3
- Classification
- Services-Computer Integrated Systems Design
- Filer status
- Non-accelerated filer
Leadership
Pay as last reported
- Mr. Steven HanleyChairman of the Board, since 2015
- Mr. Alex OvadiaChief Executive Officer$604,972
- Mr. Dan HilerowitzChief Financial Officer
- Ms. Mira RosenzweigChief Financial Officer$355,680
- Dr. Yoav KimchyChief Technology Officer, since 2005$464,653
- Mr. Joshua BelkarVice President - Operations$314,172
- Dr. Hanit Brenner-lavieVice President - Clinical Affairs
- Mr. Israel HershkoVice President - Quality Assurance and Regulatory Affairs$231,030
- Mr. Boaz ShpigelmanVice President - Research and Development$330,572
- Ms. Clara EzedIndependent Director
- Dr. Mary Jo GormanIndependent Director
- Mr. XiangQian LinIndependent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Check Cap Ltd has a unique and innovative technology that allows for the non-invasive detection of colorectal cancer.
- The company has a strong and dedicated team of researchers and scientists who are continuously working on developing and improving their technology.
- Check Cap Ltd has successfully conducted clinical trials and has received positive results, demonstrating the effectiveness of their product.
- The company has secured patents for their technology, providing them with a competitive advantage and protection of their intellectual property.
Weaknesses
- Check Cap Ltd is a relatively new company and may face challenges in establishing itself in a competitive market.
- The cost of the technology may be a barrier for widespread adoption, limiting the potential customer base.
- The product is still in the development phase and may require further clinical trials and regulatory approvals before it can be commercially available.
- The company relies heavily on external funding to support its research and development activities.
Opportunities
- The global demand for non-invasive and accurate cancer detection methods is increasing, providing Check Cap Ltd with a significant growth opportunity.
- Partnerships with pharmaceutical companies or healthcare organizations can help in accelerating the development and commercialization of the product.
- Expanding into new geographic markets can further increase the customer base and revenue potential for Check Cap Ltd.
- Advancements in medical technology and increased awareness of the importance of early cancer detection create a favorable market environment for Check Cap Ltd.
Threats
- There may be regulatory challenges and requirements that could delay or limit the commercialization of Check Cap Ltd's product.
- Competitors with similar technologies or alternative solutions may enter the market and pose a threat to Check Cap Ltd's market share.
- The reimbursement landscape and insurance coverage for non-invasive cancer detection methods may impact the adoption of Check Cap Ltd's product.
- The unpredictable nature of the healthcare industry and potential changes in healthcare policies can affect market conditions and demand for Check Cap Ltd's technology.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.